Skip to main content
. 2021 Mar 25;16(11):2299–2309. doi: 10.4103/1673-5374.309843

Figure 7.

Figure 7

In vitro inhibitor activity of the new benzimidazole derivatives on human recombinant MAO-B enzyme.

Data are presented as means from three independent experiments ± SD (n = 8). Groups were compared by one-way analysis of variance with Dunnet’s post hoc test. ***P < 0.001, vs. control group; &P < 0.05, &&P < 0.01, vs. Compound 7. MAO-B: monoamine oxidase-B. C3–C8: Compounds 3–8.